Suppr超能文献

EUS 引导下注射凝血酶和线圈植入治疗造口旁静脉曲张的技术和临床结果。

Technical and clinical outcomes following EUS-guided thrombin injection and coil implantation for parastomal varices.

机构信息

Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Department of Gastroenterology, Walsall Healthcare NHS Trust, Walsall, UK.

出版信息

BMJ Open Gastroenterol. 2023 Aug;10(1). doi: 10.1136/bmjgast-2021-000819.

Abstract

BACKGROUND AND AIMS

Bleeding from parastomal varices causes significant morbidity and mortality. Treatment options are limited, particularly in high-risk patients with significant underlying liver disease and other comorbidities. The use of EUS-guided embolisation coils combined with thrombin injection in gastric varices has been shown to be safe and effective. Our institution has applied the same technique to the treatment of parastomal varices.

METHODS

A retrospective review was performed of 37 procedures on 24 patients to assess efficacy and safety of EUS-guided injection of thrombin, with or without embolisation coils for treatment of bleeding parastomal varices. All patients had been discussed in a multidisciplinary team meeting, and correction of portal hypertension was deemed to be contraindicated. Rebleeding was defined as stomal bleeding that required hospital admission or transfusion.

RESULTS

All patients had significant parastomal bleeding at the time of referral. 100% technical success rate was achieved. 70.8% of patients had no further significant bleeding in the follow-up period (median 26.2 months) following one procedure. 1-year rebleed-free survival was 80.8% following first procedure. 7 patients (29.1%) had repeat procedures. There was no significant difference in rebleed-free survival following repeat procedures. Higher age was associated with higher risk of rebleeding. No major procedure-related complications were identified.

CONCLUSIONS

EUS-guided thrombin injection, with or without embolisation coils, is a safe and effective technique for the treatment of bleeding parastomal varices, particularly for patients for whom correction of portal venous hypertension is contraindicated.

摘要

背景与目的

肠造口旁静脉曲张出血可导致严重的发病率和死亡率。治疗选择有限,特别是对于存在严重基础肝病和其他合并症的高危患者。超声内镜引导下的栓塞线圈联合注射凝血酶治疗胃静脉曲张已被证明是安全有效的。我们机构已将相同的技术应用于肠造口旁静脉曲张的治疗。

方法

对 24 例 37 例患者进行回顾性分析,评估超声内镜引导下注射凝血酶联合或不联合栓塞线圈治疗出血性肠造口旁静脉曲张的疗效和安全性。所有患者均在多学科团队会议上进行了讨论,认为纠正门静脉高压症是禁忌的。再出血定义为需要住院或输血的造口出血。

结果

所有患者在转诊时均有明显的肠造口旁出血。100%达到技术成功。70.8%的患者在一次治疗后的随访期间(中位数 26.2 个月)无进一步明显出血。首次治疗后 1 年无再出血生存率为 80.8%。7 例(29.1%)患者行重复治疗。重复治疗后无再出血生存率无显著差异。较高的年龄与再出血风险较高相关。未发现与手术相关的重大并发症。

结论

超声内镜引导下注射凝血酶联合或不联合栓塞线圈是治疗出血性肠造口旁静脉曲张的一种安全有效的技术,特别是对于那些不能纠正门静脉高压症的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db7/10423785/870bc8399af3/bmjgast-2021-000819f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验